Drug Profile


Alternative Names: Alloxanthine; Oxyprim; Oxypurinol

Latest Information Update: 21 Jan 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Developer Cardiome Pharma
  • Class Anti-ischaemics; Antigouts; Pyrazoles; Pyrimidines; Small molecules
  • Mechanism of Action Xanthine oxidase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Gout; Heart failure; Stomatitis

Most Recent Events

  • 28 Feb 2006 Oxypurinol is available for partnering worldwide for the treatment of conjestive heart failure and gout (www.cardiome.com)
  • 11 Apr 2005 Data from a media release have been added to the Heart Failure therapeutic trials section
  • 29 Dec 2004 ILEX Oncology has been acquired by Genzyme Corporation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top